Literature DB >> 7295481

U.K. drug control: retrospect and prospect.

T B Binns.   

Abstract

Mesh:

Year:  1981        PMID: 7295481      PMCID: PMC1401911          DOI: 10.1111/j.1365-2125.1981.tb01250.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Drug discovery and introduction: regulation and overregulation.

Authors:  L Lasagna
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

2.  Constraints of drug regulation on the development of new drugs.

Authors:  F Gross
Journal:  Arch Toxicol       Date:  1979-10       Impact factor: 5.153

3.  On regulating regulation.

Authors:  I Lunde; M N Dukes
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

4.  The rate of development of new drugs in the United States, 1963 through 1975.

Authors:  W M Wardell; M Hassar; S N Anavekar; L Lasagna
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

5.  A survey of products licensed in the United Kingdom from 1971-1981.

Authors:  J P Griffin; G E Diggle
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

  5 in total
  2 in total

1.  Six months experience of new procedures affecting the conduct of clinical trials in the United Kingdom.

Authors:  J P Griffin; A G Stewart
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

2.  The role of the pharmaceutical industry in diabetes research.

Authors:  G E Lovatt
Journal:  Diabetologia       Date:  1982-09       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.